Merck & Co Inc (MRK)
131.20
+0.48
(+0.37%)
USD |
NYSE |
Apr 26, 16:00
131.15
-0.05
(-0.04%)
After-Hours: 20:00
Merck Shares Outstanding: 2.533B for April 1, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 01, 2024 | 2.533B |
February 29, 2024 | 2.533B |
January 31, 2024 | 2.533B |
December 31, 2023 | 2.532B |
October 31, 2023 | 2.534B |
September 30, 2023 | 2.535B |
July 31, 2023 | 2.538B |
June 30, 2023 | 2.539B |
April 30, 2023 | 2.537B |
March 31, 2023 | 2.537B |
March 24, 2023 | 2.538B |
February 28, 2023 | 2.538B |
January 31, 2023 | 2.539B |
December 31, 2022 | 2.538B |
October 31, 2022 | 2.535B |
September 30, 2022 | 2.533B |
July 31, 2022 | 2.533B |
June 30, 2022 | 2.533B |
April 30, 2022 | 2.529B |
March 31, 2022 | 2.528B |
March 25, 2022 | 2.528B |
February 28, 2022 | 2.528B |
January 31, 2022 | 2.528B |
December 31, 2021 | 2.528B |
October 31, 2021 | 2.526B |
Date | Value |
---|---|
September 30, 2021 | 2.525B |
July 31, 2021 | 2.531B |
June 30, 2021 | 2.533B |
April 30, 2021 | 2.532B |
March 31, 2021 | 2.531B |
March 26, 2021 | 2.531B |
February 28, 2021 | 2.530B |
January 31, 2021 | 2.530B |
December 31, 2020 | 2.530B |
October 31, 2020 | 2.530B |
September 30, 2020 | 2.530B |
July 31, 2020 | 2.529B |
June 30, 2020 | 2.529B |
April 30, 2020 | 2.524B |
March 31, 2020 | 2.524B |
March 27, 2020 | 2.525B |
February 29, 2020 | 2.532B |
January 31, 2020 | 2.536B |
December 31, 2019 | 2.539B |
October 31, 2019 | 2.546B |
September 30, 2019 | 2.551B |
July 31, 2019 | 2.560B |
June 30, 2019 | 2.567B |
April 30, 2019 | 2.575B |
March 31, 2019 | 2.583B |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
2.524B
Minimum
Mar 31 2020
2.575B
Maximum
Apr 30 2019
2.535B
Average
2.533B
Median
Jan 31 2024
Shares Outstanding Benchmarks
Amgen Inc | 535.92M |
Johnson & Johnson | 2.410B |
Eli Lilly and Co | 950.77M |
Pfizer Inc | 5.647B |
Moderna Inc | 382.88M |